BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9252687)

  • 1. Differentiation of human fibroblasts to tissue macrophages by the Snyder-Theilen feline sarcoma virus (ST:FeSV): growth modulation of human tumor cell lines in agar.
    Wesseling B; Kopelovich L
    Anticancer Res; 1997; 17(4A):2599-602. PubMed ID: 9252687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conversion of human fibroblasts to tissue macrophages by the Snyder-Theilen sarcoma virus (ST:FeSV): tumouricidal effects on K-562 and Daudi tumour cell lines in monolayers and in agar suspensions.
    Kopelovich L
    Eur Cytokine Netw; 1993; 4(4):263-8. PubMed ID: 8268416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conversion of human fibroblasts to tissue macrophages by the Snyder-Theilen feline sarcoma virus (ST:FeSV): tumoricidal potential in monolayers and in agar suspensions.
    Kopelovich L
    Eur Cytokine Netw; 1992; 3(1):63-9. PubMed ID: 1316189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conversion of human fibroblasts to tissue macrophages by the Snyder-Theilen feline sarcoma virus (ST:FeSV) is associated with the de-novo expression of IL-1 alpha, IL-1 beta, IFN-alpha, TNF-alpha, GM-CSF, and CD4.
    Kopelovich L
    Eur Cytokine Netw; 1991; 2(2):99-106. PubMed ID: 1667481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation of human fibroblasts to tissue macrophages by the Snyder-Theilen feline sarcoma virus (ST:FeSV).
    Kopelovich L
    Int J Oncol; 1996 Mar; 8(3):603-7. PubMed ID: 21544403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conversion of human fibroblasts to tissue macrophages by the Snyder-Theilen feline sarcoma virus (ST:FeSV(FeLV)): productive infection by Leishmania major.
    Kopelovich L
    Immunol Lett; 1994 Dec; 43(3):195-8. PubMed ID: 7721332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histiocytic conversion of human adult skin fibroblasts by the Snyder-Theilen feline sarcoma virus.
    Kopelovich L; Wang TY
    Eur Cytokine Netw; 1990; 1(3):157-68. PubMed ID: 1966584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection of cats against progressive fibrosarcomas and persistent leukemia virus infection by vaccination with feline leukemia cells.
    Grant CK; de Noronha F; Tusch C; Michalek MT; McLane MF
    J Natl Cancer Inst; 1980 Dec; 65(6):1285-92. PubMed ID: 6253714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Replication of feline sarcoma virus in cat embryonic kidney cells in the absence of transformation.
    Popovic M; Pontén J
    Neoplasma; 1975; 22(6):589-97. PubMed ID: 1214923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation of primary human fibroblasts into tissue macrophages by the Snyder-Theilen strain of the feline sarcoma virus is associated with endoreduplication, a 1,9 translocation, phenotypic stability, and apoptosis.
    Kopelovich L
    Int J Oncol; 1996 Jun; 8(6):1223-8. PubMed ID: 21544487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro transformation of murine pre-B lymphoid cells by Snyder-Theilen feline sarcoma virus.
    Pierce JH; Aaronson SA
    J Virol; 1983 Jun; 46(3):993-1002. PubMed ID: 6304354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation of human fibroblasts to tissue macrophages by the Snyder-Theilen feline sarcoma virus is accompanied by nuclear accumulation of the tumor suppressor p53.
    Borellini F; Glazer R; Kopelovich L
    Int J Oncol; 1996 Mar; 8(3):609-15. PubMed ID: 21544404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility of human cell lines to feline leukemia virus and feline sarcoma virus.
    Azocar J; Essex M
    J Natl Cancer Inst; 1979 Nov; 63(5):1179-84. PubMed ID: 228103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Origin and functional properties of the major gene product of the Snyder-Theilen strain of feline sarcoma virus.
    Barbacid M; Beemon K; Devare SG
    Proc Natl Acad Sci U S A; 1980 Sep; 77(9):5158-62. PubMed ID: 6254060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular transformation by subgenomic feline sarcoma virus DNA.
    Barbacid M
    J Virol; 1981 Jan; 37(1):518-23. PubMed ID: 6261000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of a high-molecular-weight polyprotein translational product of Snyder-Theilen Feline sarcoma virus in malignant transformation.
    Reynolds FH; Van de Ven WJ; Blomberg J; Stephenson JR
    J Virol; 1981 Feb; 37(2):643-53. PubMed ID: 6261011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor necrosis factor alpha and interleukin 11 secreted by malignant breast epithelial cells inhibit adipocyte differentiation by selectively down-regulating CCAAT/enhancer binding protein alpha and peroxisome proliferator-activated receptor gamma: mechanism of desmoplastic reaction.
    Meng L; Zhou J; Sasano H; Suzuki T; Zeitoun KM; Bulun SE
    Cancer Res; 2001 Mar; 61(5):2250-5. PubMed ID: 11280794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three sizes of subunits in RNAs from feline sarcoma-leukaemia virus mixtures.
    Kimball PC; Rea TJ
    J Gen Virol; 1980 Dec; 51(Pt 2):295-305. PubMed ID: 6262439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical and immunological characterization of polyproteins coded for by the McDonough, Gardner-Arnstein, and Snyder-Theilen strains of feline sarcoma virus.
    Barbacid M; Lauver AV; Devare SG
    J Virol; 1980 Jan; 33(1):196-207. PubMed ID: 6154148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transformation-defective mutants of Snyder-Theilen feline sarcoma virus lack tyrosine-specific protein kinase activity.
    Barbacid M; Donner L; Ruscetti SK; Sherr CJ
    J Virol; 1981 Jul; 39(1):246-54. PubMed ID: 6168771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.